Andrew Morokoff
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Andrew Morokoff is an Associate Professor at the University of Melbourne, Australia. His research primarily focuses on glioblastoma, investigating the roles of interleukin-11, extracellular vesicles, and therapy-related mechanisms in tumor proliferation and invasion. He has published several articles exploring the impact of microRNAs and FDA-approved drugs on glioma treatment and progression.
Articles (8)
Glioblastoma is highly proliferative and invasive. However, the regulatory cytokine networks that promote glioblastoma cell proliferation and invasion into other areas of the brain are not fully defined. In the present study, we define a critical role for the IL-11/IL-11Rα signalling axis in glioblastoma proliferation, epithelial to mesenchymal transition, and invasion. We identified enhanced IL-11/IL-11Rα expression correlated with reduced overall survival in glioblastoma patients using TCGA datasets. Proteomic analysis of glioblastoma cell lines overexpressing IL-11Rα displayed a proteome that favoured enhanced proliferation and invasion. These cells also displayed greater proliferation and migration, while the knockdown of IL-11Rα reversed these tumourigenic characteristics. In addition, these IL-11Rα overexpressing cells displayed enhanced invasion in transwell invasion assays and in 3D spheroid invasion assays, while knockdown of IL-11Rα resulted in reduced invasion. Furthermore, IL-11Rα-overexpressing cells displayed a more mesenchymal-like phenotype compared to parental cells and expressed greater levels of the mesenchymal marker Vimentin. Overall, our study identified that the IL-11/IL-11Rα pathway promotes glioblastoma cell proliferation, EMT, and invasion.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Brain tumours have significant impacts on patients’ quality of life, and current treatments have limited effectiveness. To improve understanding of tumour development and explore new therapies, researchers rely on experimental models. However, reproducing tumour-associated epilepsy (TAE) in these models has been challenging. Existing models vary from cell lines to in vivo studies, but in vivo models are resource-intensive and often fail to mimic crucial features like seizures. In this study, we developed a technique in which normal rat organotypic brain tissue is implanted with an aggressive brain tumour. This method produces a focal invasive lesion that preserves neural responsiveness and exhibits epileptiform hyperexcitability. It allows for real-time imaging of tumour growth and invasion for up to four weeks and microvolume fluid sampling analysis of different regions, including the tumour, brain parenchyma, and peritumoral areas. The tumour cells expand and infiltrate the organotypic slice, resembling in vivo behaviour. Spontaneous seizure-like events occur in the tumour slice preparation and can be induced with stimulation or high extracellular potassium. Furthermore, we assess extracellular fluid composition in various regions of interest. This technique enables live cell confocal microscopy to record real-time tumour invasion properties, whilst maintaining neural excitability, generating field potentials, and epileptiform discharges, and provides a versatile preparation for the study of major clinical problems of tumour-associated epilepsy.
Year:
2023
Year:
2022
Year:
2020
Year:
2020
Collaborators (11)
Katharine Drummond
University of Melbourne
Cameron Nowell
MONASH UNIVERSITY
Theo Mantamadiotis
Associate Professor
University of Melbourne
Paul Licciardi
University of Melbourne
Adrian Achuthan
Associate Professor
University of Melbourne
Laura Vella
Florey Institute of Neuroscience and Mental Health
Tracy Putoczki
University of Melbourne
Samuel Widodo
University of Melbourne
Eric Hanssen
Professor
University of Melbourne
Chris French
University of Melbourne
Rodney B. Luwor
University of Melbourne
Make your next move.
Prepare your application
Review drafts before you send them.